Paying user area
Try for free
Celgene Corp. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Return on Equity (ROE) since 2005
- Total Asset Turnover since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Celgene Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
12 months ended: | Net product sales | Operating income (loss) | Net income (loss) attributable to Celgene |
---|---|---|---|
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The financial data reveals a notable evolution in several key performance indicators over the period analyzed. The trends indicate strong growth trajectories in revenue, operating income, and net income, albeit with some fluctuations in specific years.
- Net Product Sales
- Net product sales exhibited a consistent and robust upward trend from 2005 through 2018. Starting at $446 million in 2005, sales nearly doubled by 2006 to $812 million and continued to increase to $1.3 billion in 2007. A steep rise was observed between 2007 and 2009, reaching $2.567 billion. From 2010 onwards, sales maintained strong growth, climbing steadily each year to achieve $15.265 billion by 2018. This consistent expansion reflects a successful commercial scaling of product offerings.
- Operating Income (Loss)
- Operating income showed more volatility compared to sales. The company reported positive operating income in most years, with a significant jump from $84 million in 2005 to $425 million in 2007. However, an operating loss of $1.464 billion occurred in 2008, likely due to increased expenses or other operational challenges. Following this setback, operating income rebounded strongly, exceeding $1 billion from 2010 and continuing to grow annually. By 2018, operating income had reached $5.191 billion, indicating improved operational efficiency and profitability over time.
- Net Income (Loss) Attributable to Celgene
- Net income attributable to the company paralleled operating income trends, though with some divergence. After modest profits in 2005 and 2006, net income increased to $226 million in 2007 before turning into a large loss of $1.534 billion in 2008, in line with the operating loss. Subsequently, net income recovered and showed an increasing gradient from $777 million in 2009 to a peak of $4.046 billion in 2018. Despite some fluctuations, this pattern reflects overall improved profitability and value creation for shareholders.
In summary, the data demonstrates a pattern of rapid growth in revenue accompanied by increasing profitability, notwithstanding a challenging period in 2008. The recovery and sustained improvement in operating and net income suggest enhanced operational management and successful strategic initiatives over the long term.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Current Assets
- The current assets exhibited a general upward trend from 973 million US dollars at the end of 2005 to a peak of 14,892 million US dollars in 2017, followed by a decrease to 9,067 million US dollars in 2018. The increase over the years was significant, particularly from 2005 to 2014 where the value consistently grew, indicating enhanced liquidity or increased short-term resources. The decline in 2018 suggests a reduction in these liquid assets or a shift in asset structure during that year.
- Total Assets
- Total assets showed a strong and consistent growth trajectory, rising steadily from 1,247 million US dollars at the end of 2005 to 35,480 million US dollars by the end of 2018. This represents substantial asset accumulation over the 13-year period. The growth, particularly pronounced after 2009, indicates significant expansion, possibly through investments, acquisitions, or retained earnings growth. There are no recorded declines in total assets, underscoring sustained asset base strengthening.
- Comparative Analysis
- While current assets and total assets both increased substantially over the period, total assets grew at a faster rate, especially in the last few years. This differential growth suggests a relative increase in non-current or long-term assets compared to current assets starting around 2014. The decline in current assets in 2018 contrasts with the continued growth in total assets, which may reflect changes in asset management strategies or a shift in investment profiles towards longer-term holdings.
Balance Sheet: Liabilities and Stockholders’ Equity
Celgene Corp., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
---|---|---|---|---|
Dec 31, 2018 | ||||
Dec 31, 2017 | ||||
Dec 31, 2016 | ||||
Dec 31, 2015 | ||||
Dec 31, 2014 | ||||
Dec 31, 2013 | ||||
Dec 31, 2012 | ||||
Dec 31, 2011 | ||||
Dec 31, 2010 | ||||
Dec 31, 2009 | ||||
Dec 31, 2008 | ||||
Dec 31, 2007 | ||||
Dec 31, 2006 | ||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Current liabilities
- The current liabilities exhibited an overall upward trend over the period analyzed. Starting at US$136 million in 2005, there was a steady increase peaking at US$2112 million in 2014. Following this, a moderate decrease was observed in 2015, but the level rose again significantly in the subsequent years, reaching US$4057 million by 2018. This indicates growing short-term obligations, with notable acceleration particularly from 2010 onwards.
- Total liabilities
- Total liabilities showed a consistent increase during the period. They started at US$611 million in 2005, with gradual growth up to 2010, followed by a sharp rise thereafter. By 2018, total liabilities reached US$29319 million, representing nearly a fiftyfold increase over thirteen years. The rapid escalation, especially after 2010, suggests a significant expansion in the company's financial obligations.
- Total debt
- Total debt figures were more volatile and incomplete in early years but show a distinct growth pattern from 2010 onwards. After fluctuating around US$400 million or less in the earlier years, total debt rose substantially from US$1248 million in 2010 to US$20270 million by 2018. This trend highlights a strategic increase in borrowings or long-term debt financing during the latter half of the period.
- Stockholders’ equity
- Stockholders’ equity demonstrated growth from US$636 million in 2005, peaking at US$6525 million in 2014. However, post-2014, equity values experienced fluctuations with a general declining tendency, settling at US$6161 million in 2018. This decline following the peak suggests that despite expanding assets, there may have been pressures such as increased liabilities or losses affecting the company’s net worth.
- Overall observations
- The data reveals a company experiencing significant growth in liabilities, particularly from 2010 onwards, alongside a large increase in total debt. While equity also grew initially, it plateaued and declined in the last years of the period. This pattern may indicate a shift in the company’s financial structure towards higher leverage. The rising debt and liabilities relative to equity could imply increased financial risk and the need for careful debt management going forward.
Cash Flow Statement
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Net cash provided by operating activities
- The net cash generated from operating activities demonstrates a strong upward trajectory over the analyzed period. Starting at a modest 42 million USD in 2005, it experiences substantial growth, reaching 478 million USD by 2007 with some fluctuations in the subsequent years. Notably, there is a significant increase from 910 million USD in 2009 to over 5 billion USD by 2017, slightly declining yet remaining robust at 5.17 billion USD in 2018. This trend indicates improving operational efficiency and profitability over time.
- Net cash (used in) provided by investing activities
- Investing cash flows exhibit predominantly negative values throughout most years, indicating consistent cash outflows related to investment activities. Starting with a negative 103 million USD in 2005, there is a sharp outflow in 2007 amounting to 990 million USD, followed by persistent large cash uses in subsequent years such as 2.1 billion USD in 2010 and a peak negative outflow of over 6.4 billion USD in 2018. A few years show positive inflows or relatively lower outflows, such as 378 million USD in 2011, suggesting occasional asset disposals or returns on investments, but the general pattern is one of substantial reinvestment, possibly for growth or capital expenditures.
- Net cash provided by (used in) financing activities
- Financing activities reflect significant volatility across the years. Positive cash inflows are observed in early years with a peak of 1.22 billion USD in 2006, and again a substantial inflow of 4.6 billion USD in 2014, indicating capital raising or borrowing events. However, other periods show notable cash outflows, such as 2011 and later years, where financing cash flow is negative, indicating repayments or dividend distributions. This fluctuation suggests an active management of capital structure, alternating between raising funds and deleveraging or shareholder returns.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
- Basic Earnings Per Share (EPS)
- The basic earnings per share displayed a fluctuating pattern over the years. Initially, from 2005 to 2007, EPS increased modestly from 0.10 to 0.30. However, a significant decline occurred in 2008, with EPS dropping sharply to -1.73, indicating a loss in that year. After 2008, there was a consistent recovery and growth trend, with EPS rising steadily from 0.85 in 2009 to 5.65 in 2018. This demonstrates a strong improvement in profitability following the 2008 downturn, culminating in a noteworthy increase by 2018.
- Diluted Earnings Per Share (EPS)
- The diluted earnings per share followed a similar trajectory to the basic EPS. It rose slightly from 0.09 in 2005 to 0.27 in 2007, followed by a sharp decline to -1.73 in 2008. From 2009 onward, diluted EPS showed a continuous upward trend, increasing from 0.83 to 5.51 in 2018. This parallel movement with the basic EPS reflects consistent trends in earnings performance while accounting for potential dilution effects over the years.
- Dividend Per Share
- No dividends were reported throughout the period from 2005 to 2018, indicating that the company did not distribute earnings to shareholders in the form of dividends during this timeframe.
- General Observations
- The data reveal a significant earnings setback in 2008, possibly due to an extraordinary event or operational challenges affecting profitability. Post-2008, both basic and diluted earnings per share exhibit strong recovery and growth, signaling effective management strategies enhancing earnings capacity. The absence of dividends suggests a strategy focusing on reinvestment or other uses of retained earnings rather than direct shareholder payouts.